Last reviewed · How we verify

NCT05566652: NPS_LowCrs

Neural Pressure Support for Low Pulmonary Compliance

Status unknown NA Last updated 4 January 2023
What this trial tests

NA trial testing Neural Pressure Support in Acute Respiratory Failure in 10 participants. Status unknown.

Timeline
1 December 2022
Primary endpoint
31 May 2023
31 October 2023

Quick facts

Lead sponsorPoliclinico Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment10
Start date1 December 2022
Primary completion31 May 2023
Estimated completion31 October 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Policlinico Hospital

Who can join

18 and older, any sex, with Acute Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With this interventional prospective study, we aim at comparing the effectiveness of Neural Pressure Support (NPS) in reducing respiratory work and patient-ventilator asynchronies as compared with standard Pressure Support Ventilation (PSV), in a cohort of patients with Acute Respiratory Failure (ARF) and low respiratory system compliance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Respiratory Failure

Currently open trials in the same condition.

Other Policlinico Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05566652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing